BioNTech SE Statistics Share Statistics BioNTech SE has 240.4M
shares outstanding. The number of shares has increased by 1.12%
in one year.
Shares Outstanding 240.4M Shares Change (YoY) 1.12% Shares Change (QoQ) 0.18% Owned by Institutions (%) 21.45% Shares Floating 236.73M Failed to Deliver (FTD) Shares 8,450 FTD / Avg. Volume 1.11%
Short Selling Information The latest short interest is 6.32M, so 2.63% of the outstanding
shares have been sold short.
Short Interest 6.32M Short % of Shares Out 2.63% Short % of Float 6.84% Short Ratio (days to cover) 8.92
Valuation Ratios The PE ratio is -39.76 and the forward
PE ratio is -24.38.
BioNTech SE's PEG ratio is
0.23.
PE Ratio -39.76 Forward PE -24.38 PS Ratio 9.62 Forward PS 8.4 PB Ratio 1.36 P/FCF Ratio -108.15 PEG Ratio 0.23
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for BioNTech SE.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.45,
with a Debt / Equity ratio of 0.01.
Current Ratio 7.45 Quick Ratio 7.34 Debt / Equity 0.01 Debt / EBITDA -0.69 Debt / FCF -1.04 Interest Coverage -104.31
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $406.25K Profits Per Employee $-98.24K Employee Count 6,772 Asset Turnover 0.12 Inventory Turnover 1.91
Taxes Income Tax -12.4M Effective Tax Rate 1.83%
Stock Price Statistics The stock price has increased by 1.45% in the
last 52 weeks. The beta is 1.4, so BioNTech SE's
price volatility has been higher than the market average.
Beta 1.4 52-Week Price Change 1.45% 50-Day Moving Average 109.4 200-Day Moving Average 108.44 Relative Strength Index (RSI) 42.33 Average Volume (20 Days) 758,737
Income Statement In the last 12 months, BioNTech SE had revenue of 2.75B
and earned -665.3M
in profits. Earnings per share was -2.77.
Revenue 2.75B Gross Profit 2.21B Operating Income -1.31B Net Income -665.3M EBITDA -367.1M EBIT -665.1M Earnings Per Share (EPS) -2.77
Full Income Statement Balance Sheet The company has 9.76B in cash and 254.2M in
debt, giving a net cash position of 9.51B.
Cash & Cash Equivalents 9.76B Total Debt 254.2M Net Cash 9.51B Retained Earnings 19.1B Total Assets 21.64B Working Capital 14.08B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 207.7M
and capital expenditures -452.3M, giving a free cash flow of -244.6M.
Operating Cash Flow 207.7M Capital Expenditures -452.3M Free Cash Flow -244.6M FCF Per Share -1.02
Full Cash Flow Statement Margins Gross margin is 80.32%, with operating and profit margins of -47.77% and -24.18%.
Gross Margin 80.32% Operating Margin -47.77% Pretax Margin -24.63% Profit Margin -24.18% EBITDA Margin -13.34% EBIT Margin -47.77% FCF Margin -8.89%
